Dr. Homam Alkaied joined the St. Luke’s Regional Cancer Center in
August 2015. He completed his medical school training at Damascus University
Medical School in Damascus, Syria. He then completed his internal medicine
residency, geriatrics fellowship, and hematology/oncology fellowship at
the North Shore/Long Island Jewish-Staten Island University Hospital (NSLIJSU)
program. Prior to completing his hematology/oncology fellowship, Dr. Alkaied
served as a clinical assistant professor at SUNY Health Sciences Center,
the director of the anticoagulation center at NSLIJSU, and associate program
director of the internal medicine residency training program at NSLIJSU.
In 2012 he was named research fellow of the year for the division of NSLIJSU.
After completing his hematology/oncology fellowship at NSLIJSU Dr. Alkaied
worked as a hematologist/oncologist in the Prairie Lakes Healthcare system
in Watertown, South Dakota. While there Dr. Alkaied developed a reputation
as a tremendous doctor, and his services were highly sought after. He
was the institutional principal investigator on nine clinical trials,
and is currently the St. Luke’s Hospital institutional principal
investigator on a trial evaluating the impact of daratumumab on multiple
myeloma. Dr. Alkaied is the only certified geriatric oncologist in the area.
Dr. Alkaied has published twelve articles in various medical journals to
date. He is board certified in internal medicine, geriatrics, hematology,
and medical oncology. He is married, and has two children. His hobbies
include hiking, biking, fishing, reading, and skiing.
